Aquatic Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,903	Closed	-$208K	–	1526
2025 Q1	$208K	Buy	12,903 +1,136	+10%	+$18.3K	0.01%	922
2024 Q4	$274K	Buy	+11,767	New	+$274K	0.01%	865
2024 Q3	–	Sell	-11,800	Closed	-$277K	–	1528
2024 Q2	$277K	Buy	+11,800	New	+$277K	0.01%	666